journal article·2025-06

Dissolving Microneedles as In Situ Chemical Reaction Chambers: from Design Strategies to Versatile Biomedical Applications

Yu Tian, Lili Xia, Xinran Song, Yu Chen

Advanced Functional Materials· Volume 35· Issue 23
Publisher page

Abstract

Abstract The skin microenvironment is a highly intricate and dynamic system, characterized by an acidic pH, a diverse microbiota, various metabolites, and numerous enzymes, creating both challenges and opportunities for the development of innovative drug delivery systems. Dissolving Microneedles (MNs) have emerged as a promising, pain‐free alternative to conventional invasive injections, offering the ability to deliver therapeutics through gradual degradation within the skin's interstitial fluids. Building upon the unique properties of both the skin microenvironment and dissolving MNs, a novel concept is introduced wherein dissolving MNs serve as in situ chemical reaction chambers. In this framework, MNs can deliver chemical reactants or catalysts to the skin, enabling the initiation of specific chemical reactions, such as prodrug activation for targeted therapy, the degradation of harmful metabolites, or the enhanced synthesis of beneficial molecules. Moreover, this review systematically explores the potential of dissolving MNs as chemical reaction chambers, discussing key aspects such as their sustained release mechanisms, design strategies, and a range of therapeutic applications. Finally, a forward‐looking perspective is provided on the future development of dissolving MNs, addressing the challenges and opportunities for their broader clinical translation and application in personalized medicine.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Protein Interaction Studies and Fluorescence Analysis · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Medicine Shanghai University Shanghai 200444 P. R. China

Materdicine Lab School of Life Sciences Shanghai University Shanghai 200444 P. R. China

Shanghai Institute of Materdicine Shanghai 200051 P. R. China

Funding

Shanghai Shuguang Program · National Natural Science Foundation of China

References (100+)

Show source-provided references
1. 10.1016/j.mtbio.2023.10057910.1016/j.mtbio.2023.100579 ↗
2. 10.1016/j.jconrel.2020.12.01910.1016/j.jconrel.2020.12.019 ↗
3. 10.1016/j.isci.2020.10201210.1016/j.isci.2020.102012 ↗
4. 10.1038/nbt.150410.1038/nbt.1504 ↗
5. 10.1021/js98004210.1021/js980042 ↗
6. 10.1016/j.carbpol.2021.11809810.1016/j.carbpol.2021.118098 ↗
7. 10.3390/molecules2619591210.3390/molecules26195912 ↗
8. 10.1002/EXP.2021017010.1002/EXP.20210170 ↗
9. 10.1016/j.jconrel.2022.05.04510.1016/j.jconrel.2022.05.045 ↗
10. 10.1016/j.mib.2023.10231110.1016/j.mib.2023.102311 ↗
11. 10.3390/ijms2208384910.3390/ijms22083849 ↗
12. 10.3390/gels910080610.3390/gels9100806 ↗
13. 10.1016/j.lfs.2021.11987710.1016/j.lfs.2021.119877 ↗
14. 10.3390/pharmaceutics1602020010.3390/pharmaceutics16020200 ↗
15. 10.1016/j.mattod.2022.12.00710.1016/j.mattod.2022.12.007 ↗
16. 10.1002/jps.2456310.1002/jps.24563 ↗
17. 10.1007/s13346-016-0332-910.1007/s13346-016-0332-9 ↗
18. 10.1016/j.jconrel.2016.08.03110.1016/j.jconrel.2016.08.031 ↗
19. 10.1016/j.ejpb.2020.12.00610.1016/j.ejpb.2020.12.006 ↗
20. 10.1016/j.ejpb.2020.12.02010.1016/j.ejpb.2020.12.020 ↗
21. 10.1016/j.ejps.2020.10546910.1016/j.ejps.2020.105469 ↗
22. 10.1007/s13346-021-01057-710.1007/s13346-021-01057-7 ↗
23. 10.1021/acsabm.0c0067110.1021/acsabm.0c00671 ↗
24. 10.1016/j.xphs.2017.11.01310.1016/j.xphs.2017.11.013 ↗
25. 10.1016/j.jconrel.2017.10.00510.1016/j.jconrel.2017.10.005 ↗
26. 10.1016/j.ijpx.2020.10004710.1016/j.ijpx.2020.100047 ↗
27. 10.1016/j.ejps.2021.10604010.1016/j.ejps.2021.106040 ↗
28. 10.1016/j.ijpharm.2023.12333510.1016/j.ijpharm.2023.123335 ↗
29. 10.1002/adhm.20230025010.1002/adhm.202300250 ↗
30. 10.1016/j.jconrel.2021.10.00110.1016/j.jconrel.2021.10.001 ↗
31. 10.3390/pharmaceutics1401000510.3390/pharmaceutics14010005 ↗
32. 10.1016/j.actbio.2017.11.00410.1016/j.actbio.2017.11.004 ↗
33. 10.1208/s12249-021-02136-110.1208/s12249-021-02136-1 ↗
34. 10.1021/acsami.2c2281410.1021/acsami.2c22814 ↗
35. 10.1073/pnas.190217911610.1073/pnas.1902179116 ↗
36. 10.1016/j.ijpharm.2023.12310810.1016/j.ijpharm.2023.123108 ↗
37. 10.1208/s12249-023-02604-w10.1208/s12249-023-02604-w ↗
38. 10.1021/acsami.2c1924110.1021/acsami.2c19241 ↗
39. 10.1016/j.ijpharm.2021.12088510.1016/j.ijpharm.2021.120885 ↗
40. 10.3390/mi1202016710.3390/mi12020167 ↗
41. 10.1089/jop.2021.008910.1089/jop.2021.0089 ↗
42. 10.1039/D2BM01836E10.1039/D2BM01836E ↗
43. 10.1016/j.ijpharm.2024.12382610.1016/j.ijpharm.2024.123826 ↗
44. 10.1016/j.ajps.2023.10077610.1016/j.ajps.2023.100776 ↗
45. 10.1021/acsmaterialslett.3c0028710.1021/acsmaterialslett.3c00287 ↗
46. 10.1016/j.bioactmat.2020.02.00410.1016/j.bioactmat.2020.02.004 ↗
47. 10.1016/j.ijbiomac.2023.12798810.1016/j.ijbiomac.2023.127988 ↗
48. 10.3390/ijms2304203410.3390/ijms23042034 ↗
49. 10.1016/j.biomaterials.2008.09.00710.1016/j.biomaterials.2008.09.007 ↗
50. 10.1021/acsami.4c1727110.1021/acsami.4c17271 ↗
51. 10.3390/polym1610139610.3390/polym16101396 ↗
52. 10.1021/acsbiomaterials.3c0013710.1021/acsbiomaterials.3c00137 ↗
53. 10.1002/adfm.20210699910.1002/adfm.202106999 ↗
54. 10.3390/polym1608104110.3390/polym16081041 ↗
55. 10.1016/j.ijpharm.2024.12384710.1016/j.ijpharm.2024.123847 ↗
56. 10.2147/IJN.S37522910.2147/IJN.S375229 ↗
57. 10.20965/jrm.2020.p040110.20965/jrm.2020.p0401 ↗
58. 10.1021/bm301293d10.1021/bm301293d ↗
59. 10.1093/nar/28.12.241310.1093/nar/28.12.2413 ↗
60. 10.1016/j.actbio.2018.04.02510.1016/j.actbio.2018.04.025 ↗
61. 10.1080/17425247.2019.163511610.1080/17425247.2019.1635116 ↗
62. Moradi L. · Trends Pharm. Sci. · 2019 · 5 · 25
63. 10.1002/wnan.188410.1002/wnan.1884 ↗
64. 10.1021/acs.nanolett.3c0191410.1021/acs.nanolett.3c01914 ↗
65. 10.1021/acsnano.3c0952110.1021/acsnano.3c09521 ↗
66. 10.7150/thno.8411810.7150/thno.84118 ↗
67. 10.1186/s12951-024-02398-410.1186/s12951-024-02398-4 ↗
68. 10.1016/j.microc.2024.11095410.1016/j.microc.2024.110954 ↗
69. 10.1016/j.bioactmat.2024.03.00610.1016/j.bioactmat.2024.03.006 ↗
70. 10.1021/acsnano.4c0042310.1021/acsnano.4c00423 ↗
71. 10.1016/j.jconrel.2020.06.03910.1016/j.jconrel.2020.06.039 ↗
72. 10.1002/adfm.20211074610.1002/adfm.202110746 ↗
73. 10.1080/10717544.2023.222636710.1080/10717544.2023.2226367 ↗
74. 10.1002/EXP.2021008310.1002/EXP.20210083 ↗
75. 10.1021/acs.molpharmaceut.6b0083910.1021/acs.molpharmaceut.6b00839 ↗
76. 10.1007/s13346-023-01406-810.1007/s13346-023-01406-8 ↗
77. 10.1007/s11706-021-0532-110.1007/s11706-021-0532-1 ↗
78. 10.1016/j.addr.2022.11449610.1016/j.addr.2022.114496 ↗
79. 10.1002/smll.20230537410.1002/smll.202305374 ↗
80. Chen X. · ACS Nano · 2024 · 18
81. 10.1021/acssuschemeng.9b0114810.1021/acssuschemeng.9b01148 ↗
82. 10.1016/j.cclet.2023.10938110.1016/j.cclet.2023.109381 ↗
83. 10.1002/adma.20180573010.1002/adma.201805730 ↗
84. 10.1007/s13346-024-01581-210.1007/s13346-024-01581-2 ↗
85. 10.1007/s13346-024-01559-010.1007/s13346-024-01559-0 ↗
86. 10.1016/j.jconrel.2020.09.05310.1016/j.jconrel.2020.09.053 ↗
87. 10.2147/IJN.S36552310.2147/IJN.S365523 ↗
88. 10.1016/j.ijpharm.2022.12210810.1016/j.ijpharm.2022.122108 ↗
89. 10.3389/fimmu.2023.125668710.3389/fimmu.2023.1256687 ↗
90. 10.1002/adhm.20220295910.1002/adhm.202202959 ↗
91. 10.1016/j.mtbio.2023.10064910.1016/j.mtbio.2023.100649 ↗
92. 10.1039/D1TB00141H10.1039/D1TB00141H ↗
93. 10.3390/pharmaceutics1406125510.3390/pharmaceutics14061255 ↗
94. 10.1021/acs.biomac.2c0127010.1021/acs.biomac.2c01270 ↗
95. 10.1021/acsbiomaterials.3c0181010.1021/acsbiomaterials.3c01810 ↗
96. 10.1039/D3BM00182B10.1039/D3BM00182B ↗
97. 10.1016/j.apsb.2023.02.01110.1016/j.apsb.2023.02.011 ↗
98. 10.1016/j.apsb.2020.08.00810.1016/j.apsb.2020.08.008 ↗
99. 10.1038/s41551-018-0337-410.1038/s41551-018-0337-4 ↗
100. 10.1016/j.jconrel.2022.04.05110.1016/j.jconrel.2022.04.051 ↗